Nevin Manimala

J Periodontal Res. 2021 Feb 28. doi: 10.1111/jre.12859. Online ahead of print.

ABSTRACT

OBJECTIVE: The aim of this study was to determine differences in GCF and serum levels of fractalkine/CX3CL1 and its receptor/ CX3CR1 between the patients with stage III/grade B periodontitis and periodontally healthy subjects.

BACKGROUND: Fractalkine (CX3CL1), the only member of CX3C chemokine family, is involved in the pathogenesis of several systemic inflammatory diseases’ disorders including rheumatoid arthritis, cardiovascular diseases, tonsillitis, and diabetes mellitus. It has critical functions in inflammatory cell migration, adhesion, and proliferation.

METHODS: 20 stage III/grade B periodontitis (P) and 20 healthy individuals (control; C) were included in this clinical study (all never smokers and systemically healthy). Clinical periodontal parameters were measured. Serum and GCF levels of CX3CL1, CX3CR1, and IL-1β were quantified by enzyme-linked immunosorbent assay and reported as total amounts and concentration.

RESULTS: The GCF concentrations and also total amount of CX3CL1, CX3CR1, and IL-1β were statistically significantly higher in the patients with periodontitis compared with control group (P < 0.05). CX3CL1, CX3CR1, and IL-1β levels in the GCF were significantly and positively correlated with all the clinical periodontal parameters (PI, PPD, BOP, and CAL; P < 0.01, P < 0.05). There was a significant correlation between IL-1β, CX3CL1, and CX3CR1 concentrations in the GCF (respectively; r = 0.838 and r = 0.874, P < 0.01).

CONCLUSION: Fractalkine and its receptor may play role in mechanisms through the regulation of inflammation or on the pathogenesis of periodontal disease.

PMID:33641164 | DOI:10.1111/jre.12859

J Periodontal Res. 2021 Feb 28. doi: 10.1111/jre.12860. Online ahead of print.

ABSTRACT

BACKGROUND AND OBJECTIVE: Different evidence has shown that Galectins have a key role as modulators of cell surface functions and signaling in a wide range of inflammatory diseases during their preclinical stages. The aim of this study was to analyze the association and impact of periodontitis and coronary heart disease (CHD) on salivary and serum Galectin-3 in patients with periodontitis and CHD.

MATERIALS AND METHODS: For the present study, healthy controls (n = 38), periodontitis (n = 40), CHD (n = 39), and a combination of periodontitis +CHD (n = 38) patients were enrolled and analyzed. In each patient, demographic characteristics and a full-mouth clinical periodontal examination were achieved. Moreover, serum and salivary samples were collected to assess Galectin-3 and Endothelin-1 (ET-1) levels. The Jonckheere-Terpstra p-trend and Spearman’s correlation tests as well as uni- and linear regression analyses were used to analyze the study data.

RESULTS: Patients with periodontitis (serum, p = .003; saliva, p < .001) and periodontitis + CHD groups (serum p = .004; saliva, p < .001) had higher median serum and salivary concentrations of Galectin-3 in comparison with CHD and healthy controls. Serum (p = .006) and salivary (p = .009) Galectin-3 levels were significantly correlated with serum ET-1. The multivariate regression analysis highlighted that periodontitis (p = .047) was the significant predictor of serum Galectin-3 levels while ET-1 (p = .028) was the significant predictor of salivary Galectin-3 levels.

CONCLUSION: The results showed that patients with periodontitis and periodontitis + CHD presented significant higher serum and salivary Galectin-3 levels in comparison with CHD patients and healthy subjects. Periodontitis and ET-1 were the significant predictors of serum and salivary Galectin-3 levels, respectively.

PMID:33641161 | DOI:10.1111/jre.12860

West Afr J Med. 2021 Feb;38(2):152-157.

ABSTRACT

BACKGROUND: Blood transfusion is a lifesaving procedure with varying indications. Neonates, especially the extremely preterm are among the most frequent recipients of blood products. The indications could be from anaemia of prematurity or pathological causes such as haemolysis from ABO or rhesus incompatibility, neonatal sepsis and acute haemorrhage, among others.

OBJECTIVE: To determine the rate, indications and outcome of blood transfusion in neonates at Federal Teaching Hospital Gombe, Nigeria.

METHODOLOGY: The study was retrospective and included 96 neonates who received blood transfusion at the SCBU of Federal Teaching Hospital Gombe from January, 2015 to December, 2019. Data was extracted from patients’ medical records and analysed using IBM SPSS statistics version 24.

RESULTS: The prevalence of blood transfusion was 3.5% with top up blood transfusion being the most frequent, 63 (65.6%), form. Half of the patients, 48(50%), received fresh whole blood while 45 (46.9%) received packed red cells, other types of blood products accounted for 3.1%. The most common indication for exchange blood transfusion was severe hyperbilirubinaemia followed by severe anaemia. Similarly, severe anaemia and acute haemorrhage were the main indications for top-up transfusion. Seventy-four (77.1%) patients who received transfusion were discharged while 22 (22.9%) died. Blood transfusion was significantly related to the place of delivery and admitting unit.

CONCLUSION: The rate of blood transfusion was low, severe hyperbilirubinaemia and severe anaemia were the main indications for blood transfusion in this study. Mortality among transfused neonates was high.

PMID:33641150

West Afr J Med. 2021 Feb;38(2):125-130.

ABSTRACT

BACKGROUND: The effect of hypertension on the vascular system leads to Target Organ Damage (TOD). The cochlea is one of the target organs affected by hypertension, giving rise to Sensorineural Hearing Loss (SNHL).

OBJECTIVE: To determine the prevalence and pattern of Sensorineural Hearing Loss (SNHL) among hypertensives.

DESIGN: Case-Control Study.

SETTING: Tertiary hospital.

SUBJECTS: Two hundred and twenty six hypertensives, aged 21 to 60 years and a corresponding number of age and sex matched control.

METHODOLOGY: Eligible participants were prospectively evaluated. Their blood pressures were verified, hearing thresholds assessed through Pure Tone Audiometry, Pure Tone Average were calculated and the types and degree of hearing loss were confirmed. Data was analyzed using SPSS 21 and statistical significance was set at p-value 0.05.

RESULTS: Each group had 127 (56.19% ) females and 99 ( 43.81 % ) males. The difference in the mean age between the cases (40.02 ± 0.70years) and the controls (37.42 ± 0.47years) was not statistically significant (p = 0.542).The difference in the mean Pure Tone Average in dBHL between the cases (15.53± 6.95) and the controls (13.98 ± 4.35) was significant (p = 0.005) with a 12.83% prevalence of SNHL among the hypertensives against 1.77% in the controls. Majority (96.6 %) of them demonstrated bilateral, symmetrical, mild SNHL with 51.7% of them being above 50 years. The odds ratio in this study was 8.17 (p = 0.0001).

CONCLUSION: This study demonstrated a SNHL prevalence of 12.83% with a mild, bilateral, symmetrical pattern among hypertensives; increasing with advanced age and an eight-fold risk of occurrence.

PMID:33641146

West Afr J Med. 2021 Feb;38(2):109-113.

ABSTRACT

BACKGROUND: We assessed clinical parameters in patients confirmed to have COVID-19 in relation to arterial hypoxaemia and survival.

METHODOLOGY: This was a retrospective chart review of patients who were confirmed positive for SARS-CoV-2 virus by Real Time-Polymerase Chain Reaction (RT-PCR) testing. Data extracted from patients’ case files included patient demographics, presenting symptoms, provisional diagnoses, and outcomes of hospitalisation. Descriptive variables were summarized; proportions were compared using Chi-square tests, and independent predictors of mortality were assessed using multivariate regression analysis. A p-value of < 0.05 was considered as statistically significant.

RESULTS: There were a total of 61 patients with positive RT-PCR testing: mean age ± SD (minimum – maximum) was 53.0 ± 18.5 (5 months – 90) years. Persons aged 60 years and above were the largest group (n=24, 39.3%). More than half were male (n=35, 57.4%); about 43% had one morbidity; 41.0% had at least two co-morbidities. The mean (SD) arterial oxygen saturation (SpO2) was 86.9% ± 16.7. Patients who were clinically dyspnoeic at presentation, and who had co-morbidities were significantly more hypoxaemic (p = 0.026 and 0.04, respectively). Significantly more patients who had normal oxygen saturation at presentation survived (p = 0.006). None of these variables was an independent predictor of mortality, however.

CONCLUSION: Arterial hypoxaemia was significantly associated with dyspnoea and underlying disease, and normal oxygen saturation at presentation was significantly associated with survival. Hospital managers and clinicians may thus prioritize routine pulse oximetry, supplemental oxygen therapy and management of co-morbidities in the COVID-19 fight.

PMID:33641143

Eur Cell Mater. 2021 Feb 23;41:204-215. doi: 10.22203/eCM.v041a15.

ABSTRACT

The demand for bone grafting procedures in various fields of medicine is increasing. Existing substitutes in clinical practice do not meet all the criteria required for an ideal bone scaffold, so new materials are being sought. This study evaluated bone regeneration using a critical-size Wistar rat’s calvarial defect model. 12 male and 12 female rats were evenly divided into 3 groups: 1. Negative and positive (Geistlich Bio-Oss®) controls; 2. polylactic acid (PLA) and PLA/hydroxyapatite (HA); 3. PLA/HA cellularised with dental pulp stem cells (DPSC) and PLA/HA extracellular matrix (ECM) scaffolds. PLA/HA filament was created using hot-melt extrusion equipment. All scaffolds were fabricated using a 3D printer. DPSC were isolated from the incisors of adult Wistar rats. The defects were evaluated by micro-computed tomography (µCT) and histology, 8 weeks after surgery. µCT revealed that the Bio-Oss group generated 1.49 mm3 and PLA/HA ECM 1.495 mm3 more bone volume than the negative control. Histology showed a statistically significant difference between negative control and both (Bio-Oss and PLA/HA ECM) groups in rats of both genders. Moreover, histology showed gender-specific differences in all experimental groups and a statistically significant difference between cellularised PLA/HA and PLA/HA ECM groups in female rats. Qualitative histology showed the pronounced inflammation reaction during biodegradation in the PLA group. In conclusion, the bone-forming ability was comparable between the Bio-Oss and PLA/HA ECM scaffolds. Further research is needed to analyse the effects of ECM and PLA/HA ratio on osteoregeneration.

PMID:33641140 | DOI:10.22203/eCM.v041a15

Environ Sci Pollut Res Int. 2021 Feb 28. doi: 10.1007/s11356-021-13168-2. Online ahead of print.

ABSTRACT

Amphibians are the most important vulnerable non-target vertebrate group that are affected by pesticides. Most previous studies have confirmed the destructive effects of pesticides. But, so far, no comprehensive studies have been carried out in Iran. Therefore, to estimate the mortality rate of frogs during the growing season in different cultivating systems, we examined the presence of pesticides in water and substrate as indicators of habitat quality and in the liver tissue of Marsh frog Pelophylax ridibundus (Pallas, 1771), enclosed in the prepared cages at five rice paddy fields in Mazandaran province, Iran. The measurement of pollution was done using mass gas chromatography method and statistical analyses by Minitab software. Furthermore, the probable movement pattern of free frogs was analyzed using capture-mark-recapture method. Thirteen pesticides were detected both in the habitat and in frogs’ liver tissue. Among them ß-Mevinphos, Fenitrothion, Bromofos, and Trifluralin had the most frequent occurrence in liver tissue, and Diazinon with concentrations up to 517.8 μg/Kg had the highest concentration. Furthermore, there is a significant correlation (R² > 0.96) between water quality and frogs’ contamination, whereas, no correlation was observed between substrate pollution and frogs’ contamination. Pesticide concentrations were higher in two stations but lower than lethal doses to frogs, so that no mortality was observed at any of the stations. However, some specimens had a considerable muscle atrophy. Despite no significant movement pattern was detected, we can expect that if this trend continues, in a long term, they will face a reduction in the survival rate.

PMID:33641106 | DOI:10.1007/s11356-021-13168-2

Environ Sci Pollut Res Int. 2021 Feb 27. doi: 10.1007/s11356-021-13047-w. Online ahead of print.

ABSTRACT

Organochlorine pesticides (OCPs) have been used globally to boost food production. Although banned, due to their prolonged toxic effects but their residue still impacts the quality of primary and processed agricultural products. This study assesses the levels of residual OCPs (α,β,δ-HCH, heptachlor, heptachlor epoxide, chlordane, methoxychlor, aldrin, dieldrin, endrin, endrin aldehyde, endrin ketone, endosulfan, endosulfan sulfate, 1,1-dichloro-2,2-bis(p-chlorophenyl)ethane (DDD), 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE), and 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT)) in food commonly consumed in Lagos and Ibadan, Southwest, Nigeria. Health risk associated with human exposure via food intake was evaluated with a statistical predictive model. About 248 composite food samples from 8 categories were analyzed in Lagos and Ibadan. Sample extraction and clean-up were by QueChERS method and extracts injected into GC-μECD. ƩDDT concentration was highest in meat products, aquatic foods, dairy products, edible oils, fruits, and cereals, while ƩHCHs were highest in chicken eggs and vegetables. ƩOCP concentrations (ng/g) in food categories were 6.09±1.6-6.85±0.9 (meat), 5.29±2.0-12.3±14 (aquatic foods), 4.86±1.7-5.89±0.8 (dairy products), 4.53±0.8-6.32±1.1 (edible oils), 3.32±1.3 (eggs), 3.54±1.0-4.80±1.5 (fruits), 4.16±2.7-4.40±0.8 (vegetables), and 6.12±2.0-6.62±0.9 (cereals). The estimated average daily intake of OCPs was 5.91, 12.5, 4.41, 6.40, 1.53, 5.14, 3.95, and 16.7 ng/kg bw/day through the consumption of meat products, aquatic foods, dairy products, edible oils, chicken eggs, fruits, vegetables, and cereals, respectively. The health risk of residual OCPs via ingestion of foods considered in this study was <1, which implied no potential health risk at the current consumption rate. However, regular monitoring of OCPs residues in food is highly recommended. Finally, the method scaled the analytical Eco-Scale evaluation and Green Analytical Chemical Procedure Index as “an acceptable green analysis method.”

PMID:33641099 | DOI:10.1007/s11356-021-13047-w

Diabetes Ther. 2021 Feb 27. doi: 10.1007/s13300-021-01025-x. Online ahead of print.

ABSTRACT

INTRODUCTION: In this meta-analysis, we aimed to systematically compare the 10-year outcomes of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with type 2 diabetes mellitus (T2DM) suffering from left main coronary artery disease (LMCD).

METHODS: Medical Literature Analysis and Retrieval System Online (MEDLINE), http://www.ClinicalTrials.gov , Excerpta Medica dataBASE (EMBASE), Cochrane Central, Web of Science, and Google scholar were searched for publications comparing 10-year outcomes of PCI versus CABG in patients with T2DM suffering from LMCD. Cardiovascular outcomes were considered as the clinical endpoints. Statistical analysis was carried out using RevMan software (version 5.4). Risk ratios (RR) with 95% confidence intervals (CI) were used to represent the data after analysis.

RESULTS: Eight studies (three randomized trials and five observational studies) with a total number of 3835 participants with T2DM were included in this analysis; 2340 participants were assigned to the PCI group and 1495 participants were assigned to the CABG group. Results of this analysis showed that mortality (RR 0.85, 95% CI 0.73-1.00; P = 0.05), myocardial infarction (RR 0.53, 95% CI 0.35-0.80; P = 0.002), repeated revascularization (RR 0.34, 95% CI 0.26-0.46; P = 0.00001), and target vessel revascularization (RR 0.26, 95% CI 0.18-0.38; P = 0.00001) were significantly higher with PCI when compared to CABG in these patients with diabetes and LMCD. Major adverse cardiac and cerebrovascular events were also significantly higher with PCI at 10 years (RR 0.67, 95% CI 0.49-0.92; P = 0.01). However, CABG was associated with a significantly higher risk of stroke (RR 2.16, 95% CI 1.39-3.37; P = 0.0007).

CONCLUSIONS: During a long-term follow-up time period of 10 years, PCI was associated with worse clinical outcomes compared to CABG in these patients with T2DM suffering from LMCD. However, a significantly higher risk of stroke was observed with CABG. This piece of information might be vital in order to carefully choose and prevent complications following revascularization in such patients.

PMID:33641081 | DOI:10.1007/s13300-021-01025-x

Acta Gastroenterol Belg. 2021 Jan-Mar;84(1):65-72.

ABSTRACT

AIM: The aim of this retrospective multicenter study was to evaluate the differences in the timing for starting systemic therapies as the first-line treatment for hepatocellular carcinoma (HCC).

METHODS: A total of 375 patients with HCC treated with sorafenib from May 2009 to March 2018 and 56 patients treated with lenvatinib from March 2018 to November 2018 at our affiliated hospitals were included in this study.

RESULTS: The median ages of the sorafenib and lenvatinib groups were 71.0 (interquartile range [IQR]: 64.0-77.0) and 73.5 (IQR: 68.0 -80.0) years old, and 300 (80.0%) and 42 (75.0%) patients were men, respectively. The Barcelona Clinic Liver Cancer stage was early, intermediate and advanced in 39 patients (10.4%), 133 patients (35.5%) and 203 patients (54.1%) in the sorafenib group and 1 patient (1.8%), 17 patients (30.4%) and 38 patients (67.9%) in the lenvatinib group, respectively. In the analysis of intermediate HCC, patients who satisfied the criteria of TACE failure/refractoriness (P=0.017), those with ALBI grade 1 (P=0.040), and those with a serum AFP level < 200 ng/ml (P=0.027) were found more frequently in the lenvatinib group than in the sorafenib group, with statistical significance. The objective response rate (ORR) of lenvatinib was 34.8% in the overall patients and 46.7% in the intermediate-stage HCC patients, which was significantly higher than sorafenib (P=0.001, P=0.017).

CONCLUSIONS: The emergence of lenvatinib has encouraged physicians to start systemic chemotherapy earlier in intermediatestage HCC patients.

PMID:33639695